Abbott Laboratories
DE ˙ XTRA ˙ US0028241000
75,22 € ↑1,20 (1,62%)
2026-06-03
AKTIENPREIS
SecurityDE:ABL / Abbott Laboratories
InstitutionAlps Advisors Inc
Latest Disclosed Ownership173,326 shares
Latest Disclosed Value $ 17,795,380
Alps Advisors Inc reports 8.42% decrease in ownership of ABL / Abbott Laboratories

On May 8, 2026 - Alps Advisors Inc filed a 13F-HR form disclosing ownership of 173,326 shares of Abbott Laboratories (DE:ABL) valued at $15,394,815 USD as of March 31, 2026. The entity filed a previous 13F-HR on February 12, 2026 disclosing 189,263 shares of Abbott Laboratories. This represents a change in shares of -8.42% during the quarter. The current value of the position is $13,037,582 USD.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date		 Effective
Date		Form Security Class ID Avg Price
Paid (Est)		 Reported
Shares		 ΔShares ΔShares
(%)		 Reported
Value
(x1000)		 ΔValue
(%)		 Alloc
(%)		 ΔAlloc ΔAlloc (%) Cost Basis
(x1000)		 Unrealized
Gain/Loss
(x1000)
2026-05-08 2026-03-31 13F ABBOTT LABORATORIES COM 002824100 173,326 -15,937 -8.42 17,795 -24.95 0.0837
2026-02-12 2025-12-31 13F ABBOTT LABS COM 002824100 189,263 -1,064 -0.56 23,713 -6.98 0.1381
2025-11-05 2025-09-30 13F ABBOTT LABS COM 002824100 190,327 82,455 76.44 25,492 73.76 0.1420
2025-08-11 2025-06-30 13F ABBOTT LABS COM 002824100 107,872 -488 -0.45 14,672 2.07 0.0846
2025-04-30 2025-03-31 13F ABBOTT LABS COM 002824100 108,360 3,629 3.47 14,374 21.33 0.0834
2025-02-13 2024-12-31 13F ABBOTT LABS COM 002824100 104,731 -46 -0.04 11,846 -0.83 0.0748
2024-11-12 2024-09-30 13F ABBOTT LABS COM 002824100 104,777 37,331 55.35 11,946 70.45 0.0799
2024-08-13 2024-06-30 13F ABBOTT LABS COM 002824100 67,446 1 0.00 7,008 -8.57 0.0481
2024-05-14 2024-03-31 13F ABBOTT LABS COM 002824100 67,445 882 1.33 7,666 4.63 0.0543
2024-02-14 2023-12-31 13F ABBOTT LABS COM 002824100 66,563 331 0.50 7,327 14.22 0.0576
2023-11-14 2023-09-30 13F ABBOTT LABS COM 002824100 66,232 -27,226 -29.13 6,415 -37.04 0.0532
2023-08-14 2023-06-30 13F ABBOTT LABS COM 002824100 93,458 -4,693 -4.78 10,189 2.52 0.0885
2023-05-10 2023-03-31 13F ABBOTT LABS COM 002824100 98,151 -8,099 -7.62 9,939 -14.80 0.0878
2023-02-14 2022-12-31 13F ABBOTT LABS COM 002824100 106,250 -5,288 -4.74 11,665 8.09 0.1041
2022-11-14 2022-09-30 13F ABBOTT LABS COM 002824100 111,538 -27,488 -19.77 10,792 -28.55 0.1021
2022-08-15 2022-06-30 13F/A-1 ABBOTT LABS COM 002824100 139,026 133,426 2,382.61 15,105 2,178.28 0.1469
2022-08-11 2022-06-30 13F ABBOTT LABS COM 002824100 139,026 133,426 15,105 0.1469
2022-05-16 2022-03-31 13F ABBOTT LABS COM 002824100 5,600 -718 -11.36 663 -25.42 0.0072
2022-02-09 2021-12-31 13F ABBOTT LABS COM 002824100 6,318 3,458 120.91 889 163.02 0.0100
2021-11-15 2021-09-30 13F ABBOTT LABS COM 002824100 2,860 -3,170 -52.57 338 -51.65 0.0033
2021-08-11 2021-06-30 13F ABBOTT LABS COM 002824100 6,030 1,300 27.48 699 23.28 0.0062
2021-05-07 2021-03-31 13F ABBOTT LABS COM 002824100 4,730 550 13.16 567 23.80 0.0055
2021-02-03 2020-12-31 13F ABBOTT LABS COM 002824100 4,180 501 13.62 458 14.50 0.0052
2020-11-05 2020-09-30 13F/A-1 ABBOTT LABS COM 002824100 3,679 1,133 44.50 400 71.67 0.0059
2020-11-04 2020-09-30 13F ABBOTT LABS COM 002824100 3,679 1,133 400 5,126.4792
2020-08-05 2020-06-30 13F ABBOTT LABS COM 002824100 2,546 -282 -9.97 233 4.48 0.0031
2020-05-06 2020-03-31 13F ABBOTT LABS COM 002824100 2,828 -13,923 -83.12 223 -84.67 0.0034
2020-02-07 2019-12-31 13F ABBOTT LABS COM 002824100 16,751 -1,068 -5.99 1,455 -2.41 0.0113
2019-11-04 2019-09-30 13F ABBOTT LABS COMMON STOCK 002824100 17,819 -233 -1.29 1,491 -1.78 0.0116
2019-08-07 2019-06-30 13F ABBOTT LABS COMMON STOCK 002824100 18,052 -3,988 -18.09 1,518 -13.85 0.0112
2019-05-01 2019-03-31 13F ABBOTT LABS COMMON STOCK 002824100 22,040 -1,016 -4.41 1,762 5.64 0.0125
2019-02-04 2018-12-31 13F ABBOTT LABS COMMON STOCK 002824100 23,056 -827 -3.46 1,668 -4.79 0.0129
2018-10-25 2018-09-30 13F ABBOTT LABS COMMON STOCK 002824100 23,883 6,369 36.37 1,752 64.04 0.0115
2018-08-02 2018-06-30 13F/A-2 Abbott Laboratories COMMON STOCK 002824100 17,514 1,611 10.13 1,068 12.07 0.0070
2018-05-01 2018-03-31 13F Abbott Laboratories COMMON STOCK 002824100 15,903 15,903 953 0.0076
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.